61. Kalkeri G., Khalap N., Garry R.F. et al. Hepatitis C virus protein expression induce apoptosis in HepG2 cells // Virology. 2001. V. 282. №1. P. 26-37.
62. Kawanishi M. Anti-apoptotic function of the EBV LMP-1 and BHRF-1 proteins // Nippon. Rinsho. 1996. V. 54. №7. P. 1845-1854.
63. Kim M, Sgagias M, Deng X. et al. Apoptosis induced by adenovirus-mediated p14ARF expression in U2OS osteosarcoma cells is associated with increased Fas expression // Biochem. Biophys. Res. Commun. 2004. V. 320. №1. P. 138-144.
64. Lauli Y., Yibellini D., Caputo A. et al. The human immunodeficiency virus typy-1 Jat protein uhregulates Bcl-2 gene expression in jurhat T-cell lines and primary perpherial blood mononuclerar cells // Blood. 1995. V. 86. P. 3829-3834.
65. Kroemer G., Zamzani N., Susin S.A. Mitochondrial control of apoptosis // Immunol. Today. 1997. V. 18. №1. P. 44-51.
66. Lewis J., Wesselingh S.L., Griffin D.E., Hardwick J.M. Alphavirus-induced apoptosis in human neutrophils // J. Virol. 1996. V. 70. №3. P. 1828-1836.
67. Li C.J., Wang C., Friedman D.J., Pardee A.B. Reciprocal modulation between p53 and Tat of human immunodeficiency virus type-1 // Proc. Nal. Acad. Sci. USA. 1995. V. 92. №12. P. 5461-5464.
68. Liov S., Hayashi N., Mita E. et al. Serum level of soluble Fas antigen in сhronic hepatitis C patients // J. Hepatol. 1998. V. 29. №4. P. 517-523.
69. Liu Z.G., Hsu H., Goeddel D.V., Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death // Cell. 1996. V. 87. №3. P. 565-576.
70. Marsters S.A., Sheridan J.P., Donahue C.J. et al. Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B // Curr Biol. 1996. V. 6. №12. P.1669-1676.
71. Marsters S.A., Sheridan J.P., Pitti R.M. et al. A novel receptor for Apo2L/TRAIL contains a truncated death domain // Curr. Biol. 1997. V. 7. №12. P. 1003-1006.
72. Martinez-Lorenzo M.J., Alava M.A., Gamen S. et al. Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells // Eur. J. Immunol. 1998. V. 8. №9. P. 2714-2725.
73. McFarlane W.M., Ahmad M., Srinivasula S.M. et al. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL // J. Biol. Chem. 1997. V. 272. №41. P. 25417-25420.
74. Mongkolsapaya J., Cowper A.E., Xu X.N. et al. Lymphocyte inhibitor of TRAIL (TNF-related apoptosis-inducing ligand): a new receptor protecting lymphocytes from the death ligand TRAIL // J. Immunol. 1998. V. 160. №1. P. 3-6.
75. Nagata S. Apoptosis by death factor // Cell. 1997. V. 88. №3. P. 355-365.
76. Natoli G., Costanzo A., Ianni A. et al. Activation of SAPK/JNK by TNF Receptor 1 Through a Noncytotoxic TRAF2-Dependent Pathway // Science. 1997. V. 275. №5297. P. 200-203.
77. Ndolo T., Dhillon N.K., Nguyen H. et al. Induction of apoptosis in mature T cells // J. Virol. 2002. V. 76. №8. P. 3587-3595.
78. Newton K., Harris A.W., Bath M.L. et al. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. // EMBO J. 1998. V. 17. №3. P. 706-708.
79. Nguyen H., Mudryj M., Guadalupe M., Dandekar S. Hepatitis C virus core protein expression leads to biphasic regulation of the p21 cdk inhibitor and modulation of hepatocyte cell cycle // Virology. 2003. V. 312. №1. P. 245-253.
80. Oehm A., Behrmann I., Falk W. et al. Purification and Molecular Cloning of the APO-1 Cell Surface Antigen, a Member of the Tumor Necrosis Factor/Nerve Growth Factor Receptor Superfamily // J. Biol. Chem. 1992. V. 267. №15. P. 10709-10715.
81. Ohkawa K., Ishida H., Nakanishi F. et al. Hepatitis C virus core functions as a suppressor of cyclin-dependent kinase-activating kinase and impairs cell cycle progression. // J. Biol. Chem. 2004. V. 279. №12. P. 11719-11726.
82. Oka K., Nagano-Fujii M., Yoshida I. et al. Hepatitis C virus core protein selectively inhibits synthesis and accumulation of p21/Waf1 and certain nuclear proteins // Microbiol. Immunol. 2003. V. 47. №6. P. 429-438.
83. Oliveira Pinto L.M., Garcia S., Lecoeur H. et al. Increased sensitivity of T lymphocytes to tumor necrosis factor receptor 1 (TNFR1)-and TNFR2-mediated apoptosis in HIV infection: relation to expression of Bcl-2 and active caspase-8 and caspase-3 // Blood. 2002. V. 99. №5. P. 1666-1675.
84. Otsuka M., Kato N., Taniguchi H. et al. Hepatitis C virus core protein inhibits apoptosis via enhanced Bcl-xL expression // Virology. 2002. V. 296. №1. P.84-93.
85. Pan G., Ni J., Wei Y.F. et al. The receptor for the cytotoxic ligand TRAIL // Science. 1997. V. 277. №5327. P. 815-818.
86. Park U.S., Park S.K., Lee Y.I. et al. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells // Oncogene. 2000. V. 19. №30. P. 3384-3394.
87. Pianko S., Patella S., Ostapowicz G. et al. Fas-mediated hepatocyte apoptosis is increased by hepatitis C virus infection and alcohol consumption, and may be associated with hepatic fibrosis: mechanisms of liver cell injury in chronic hepatitis C virus infection // J. Viral. Hepat. 2001. V. 8. №6. P. 406-413.
88. Pitti R.M., Marsters S.A., Ruppert S. et al. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family // J. Biol. Chem. 1996. V. 271. №22. P. 12687-12690.
89. Polyak K., Xia Y., Zweier J.L. et al. The model for p53-induced apoptosis // Nature. 1997. V. 389. №6648. P. 300-305.
90. Roy D.J., Robert-Hebmann V., Hamington S. et al. Murine gammaherpesvirus M11 gene product inhibits apoptosis and is expressed during virus persistence // J. Virol. 2000. V. 145. №11. P. 2411-2420.
91. Schneider P., Bodmer J.L., Thome M. et al. Characterization of two receptors for TRAIL // FEBS Lett. 1997. Vol. 416. P. 329-334.
92. Screaton G.R., Mongkolsapaya J., Xu X.N. et al. TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL // Curr. Biol. 1997. V. 7. №9. P. 693-696.
93. Screaton G.R., Xu X.N., Olsen A.L. et al. LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. // Proc. Natl. Acad. Sci. U S A. 1997. V. 94. №9. P. 4615-4619.
94. Sheridan J.P.; Marsters S.A., Pitti R.M. et al. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors // Science. 1997. V. 277. P. 818-821.
95. Shu H.B., Halpin D.R., Goeddel D.V. Casper is a FADD-and caspase-related inducer of apoptosis // Immunity. 1997. V. 6. №6. P. 751-763.
96. Simon H.-U. Molecular mechanisms of programmed cell death // Apoptosis. 1996. V. 1. P. 107-109.
97. Smith C.A., Farrah T., Goodwin R.G. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death // Cell. 1994. V. 76. №6. P. 959-962.
98. Sohn S., Iaitovittch-Groisman I., Benlimame N. et al. Retroviral expression of the hepatitis B virus x gene promotes liver cell susceptibility to carcinogen-induced site specific mutagenesis // Mutant. Res. 2000. V. 460. №1. P. 17-28.
99. Suda T., Nagata S. Purification and characterization of the Fas-ligand that induces apoptosis // J. Exp. Med. 1994. V. 179. №3. P. 873-877.
100. Susin S.A., Lorenzo H.K., Zamzani N. et al. Mitochondrial release of caspase-2 and -9 during the apoptotic process // J. Exp. Med. 1999. V. 189. №2. P. 381-394.
101. Takizawa T., Matsukawa S., Higuchi Y. et al. Induction of programmed cell death (apoptosis) by infuenza virus infection in tissue culture cells // J. Gen. Virol. 1993. V. 74. №11. P. 2347-2355.
102. Tanaka M., Itai T., Adachi M., Nagata S. Downregulation of Fas ligand by shedding // Nat. Med. 1998. V. 4. №1. P. 31-36.
103. Tanaka M., Suda T., Nakamura N. Fas ligand in human serum // Nature Med. 1996. V. 2. P. 317-322.
104. Tanaka M., Suda T., Yatomi T. Lethal effect of recombinant human Fas ligand in mice pretreated with fropiobacterium asnes // J. Immunol. 1997. V. 158. №5. P. 2303-2309.
105. Tartaglia L.A., Ayres T.M., Wong G.H., Goeddel D.V. A novel domain within the 55 kd TNF receptor signals cell death // Cell. 1993. V. 74. №5. P. 845-853.
106. Tartaglia L.A., Goeddel D.V. Two TNF receptors // Immunol. Today. 1992. V. 13. №5. P. 151-153.
107. Taya N., Torimoto Y., Shindo M. et al. Fas-mediated apoptosis of peripheral blood mononuclear cells in patients with hepatitis C // Br. J. Haematol. 2000. V. 110. №1. P. 89-97.
108. Thome M., Schneider P., Hofmann K. et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors // Nature. 1997. V. 386. №6624. P. 517-524.
109. Thompson C.B. Apoptosis in the pathogenesis of diseasea // Sceince. 1995. V. 267. P. 1456-1462.
110. Tokano Y., Miyake S., Kayagaki N. et al. Soluble Fas molecule in the serum of patients with systemic lupus erythematosus // J. Clin Immunol. 1996. V. 16. №5. P. 261-265.
111. Tolstaya E.A., Romanova L.I., Kolesnikova M.S. Apoptosis-inducing and apoptosis-preventing functions of poliovirus // J. Virol. 1995. V. 69. №2. P. 1181-1189.
112. Tsukiyama-Kohara K., Tone S., Maruyama I. et al. Activation of the CKI-CDK-Rb-E2F pathway in full genome hepatitis C virus-expressing cells // J. Biol. Chem. 2004. V. 279. №15. P. 14531-14541.
113. Walczak H., Degli-Esposti M.A., Johnson R.S. et al. TRAIL-R2: a novel apoptosis-mediating receptor for TRAI. // EMBO J. 1997. V. 16. №17. P. 5386-5397.
114. Wiley S.R., Schooley K., Smolak P.J. et al. Identification and characterization of a new member of the TNF family that induces apoptosis // Immunity. 1995. V. 3. №6. P. 73-682.
115. Yang Y., Dong B., Mittelstadt P.R. et al. HIV Tat Binds Egr Proteins and Enhances Egr-dependent Transactivation of the Fas Ligand Promoter // J. Biol. Chem. 2002. V. 277. №22. P. 19482-19487.
116. Yao Z.Q., Eisen-Vandervelde A., Ray S., Hahn Y.S. HCV core/gC1qR interaction arrests T cell cycle progression through stabilization of the cell cycle inhibitor p27Kip1 // Virology. 2003. V. 314. №1. P. 271-282.
117. Yeh W.-C., Pompa J.L., McCurrach M.E. FADD: essential for embryo development and signaling from some, but not all // Science. 1998. V. 279. №5358. P. 1954-1958.
118. Yoo Y.G., Lee M.O. Hepatitis B Virus X Protein Induces Expression of Fas Ligand Gene through Enhancing Transcriptional Activity of Early Growth Response Factor // J. Biol. Chem. 2004. V. 279. №35. P.36242-36249.
119. Zhang J., Cado D., Chen A. et al. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1 // Nature. 1998. V. 392. №6673. P.296-300.
120. Zhang Y., Peng Z., Qiu G. et al. Overexpression of cyclin A in hepatocellular carcinoma and its relationship with HBx gene integration // Zhonghua Zhong Liu Za Zhi. 2002. V. 24. №4. P. 353-355.
121. Zhu N., Ware C.F., Lai M.M. Hepatitis C virus core protein enhances FADD-mediated apoptosis and suppresses TRADD signaling of tumor necrosis factor receptor // Virology. 2001. V. 283. №2. P. 178-187.
122. Zornig M., Hueber AO., Evan G. p53-dependent impairment of T-cell proliferation in FADD dominant-negative transgenic mice // Curr. Biol. 1998. V. 8. №8. P. 467-470.